# Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

> **NCT00791856** · PHASE1 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 110 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** testosterone
- **DRUG:** testosterone

## Key facts

- **NCT ID:** NCT00791856
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2013-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791856, "Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00791856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*